What an end to a great week! This is one of the most important milestones in the history of Paxman, moving one step closer to our vision.
The granting of the CPT® Category I codes is one of the most significant breakthroughs made in our efforts towards widespread adoption of Paxman’s insurance-based billing model. Our strategy has focused on the three pillars of reimbursement (coverage, coding and payment) and the 3 CPT® Category I codes give a clear coding structure, enabling us to begin to unlock further coverage and payment with far greater confidence. Critically, this will ensure that physicians and other healthcare providers providing important care to patients undergoing chemotherapy for cancer and facing the devasting side effects of chemotherapy-induced hair loss are reimbursed for this vital care.
I am incredibly grateful for my wonderful colleagues at Paxman Scalp Cooling who have supported this along with our excellent partners JD LYMON Group and Innovation Partners. Dr Steven Isakoff thank you for your dedication to patients across the USA, without you we could not have done this.
We still have so much more to do but WE continue to make progress.
#ChangingTheFaceOfCancer
Team Paxman today at #ESMO24#EONS17!
We have a lot going on at stand 313 this weekend with opportunities to find out more about #ScalpCooling from nurses' perspectives and trying out cap fitting for yourself, come and join the team!
@myESMO@cancernurseEU
Pleased to meet @ErinWysocki (MBE) Gold Medallist in Mix 4+ Rowing @ParalympicsGB
18 mths ago Erin was diagnosed with breast cancer
As a Paxman user & @scalpcooling advocate I just had to congratulate her on such an amazing comeback to the sport she loves. Wow!
#BeyondSportParis
We are hiring!
An exciting opportunity to join our growing finance team, provide support to the finance director in ensuring the finance function for trading companies in Paxman Group is compliant and up to date.
Find out more and apply here: https://t.co/ADnr8a38G0
Scalp cooling can help prevent chemotherapy-related hair loss in some patients, but it may not be the best choice for everyone.
Read what you should know: https://t.co/gVCKmBHgXU #EndCancer
The new Dutch Scalp Cooling Registry has been published adding an additional 7 years of data. It is the largest real-world multi-centre analysis of determinants for scalp cooling efficacy, where 56% of patients did not require a head covering.
Read more: https://t.co/YpmUihgmBP
We are hiring!
Exciting opportunity to join the Quality department at Paxman! We're hiring for the role of Complaint Administrator.
To find out more email Francesca Slater on [email protected]
Listen to @RichPaxman and @breastcancerorg at #SABCS23 about how we're helping more people in the US access insurance reimbursement for #scalpcooling through their treatment centers as a result of facilities implementing the Paxman Buy & Bill Model https://t.co/IIkefS28k4
Always proud of the best #CEO@RichPaxman and all he does to increase access of @scalpcooling around the world. Especially love seeing the media seek him out for questions on insurance reimbursement and the generous PAP the family has committed to. @Breastcancerorg
Recognising global influence, the International Impact Award goes to Alexandra, Claire & Richard from Paxman Scalp Coolers!
Congratulations - a truly excellent achievement and one which has positive benefits for the region!
#HelptoGrowAwards
This evening we are delighted to host our first Help to Grow Celebration and Awards event at @Lusplacecafe! Follow along for live updates as we share the excitement and unveil the remarkable award winners 🌟
#HelptoGrow#HelptoGrowAwards#BusinessSuccess
An enormous congratulations to our CEO @RichPaxman for being awarded an OBE for services to International Trade in the Kings first Birthday Honours list. We couldn't be more proud!
https://t.co/dQ7Ch6nAO4
Known for bringing joy and inspiration to her Peloton workouts, instructor Leanne Hainsby is opening up about her breast cancer diagnosis and how she knew it was more than just a hormonal cyst like doctors suggested.
We’re at the Miami Breast Cancer Conference!
With learning objectives including ongoing clinical trial opportunities and strategies for treatment-related adverse events, we’re excited to hear novel discussions from breast cancer experts.